15 years, minimum. Nothing in the pipeline is promising enough to suggest it will produce marketable results, and even if one of them did, none of them are close to market under the best of circumstances. Don't kid yourself - Histogen, Replicel et. al are failures; if any of them had shown real promise, they would have been bought out by a major pharma a long, long time ago.
If a cure happens within that timeframe, it will be from a protocol that has yet to be announced. The next treatment - not cure, not game-changer - to make it to market (IF it makes it to market) will be a bimatoprost topica that will have results slightly better than minoxidil.
If a cure happens within that timeframe, it will be from a protocol that has yet to be announced. The next treatment - not cure, not game-changer - to make it to market (IF it makes it to market) will be a bimatoprost topica that will have results slightly better than minoxidil.
Comment